{"filings":[{"id":1371756,"accession_number":"0001104659-26-079643","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2026-07-01T13:27:13+00:00","items":["1.01","2.01","2.03","3.01","3.03","5.01","5.02","5.03","7.01","9.01"],"status":"ready","headline":"Select Medical completes go-private acquisition by consortium at $16.50/share (~$3.9B enterprise)","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Consortium led by Ortenzio, Jackson, and WCAS acquires Select Medical for $16.50/share cash; equity ~$1.7B, enterprise ~$3.9B.","Stock delisted from NYSE effective July 1, 2026; company becomes private subsidiary of Parent.","Board replaced: William Frist, Daniel Thomas, Katherine Davisson, et al. depart; new directors: Russell Carson, David Chernow, Robert Ortenzio.","Entered $1B incremental term loan amendment to Select Credit Agreement to help finance the transaction.","Premium of ~18% over unaffected close (Nov 24, 2025) and ~25% over 90-day VWAP; stockholder vote approved June 26, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1306516,"accession_number":"0001104659-26-078332","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2026-06-26T21:23:20+00:00","items":["5.07","7.01","9.01"],"status":"ready","headline":"Shareholders approve acquisition by Ortenzio/Jackson/WCAS; closing on June 30, 2026","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Over 79.88% of outstanding shares (99M) voted for the Merger; unaffiliated holders approved with 76.64%.","Special Meeting turnout of 82.54% (102.3M shares); deal expected to close on or about June 30, 2026.","Advisory compensation proposal also received majority approval (52.3M for, 48.4M against).","Consortium led by Robert Ortenzio, Martin Jackson, and WCAS to take Select Medical private."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1177076,"accession_number":"0001104659-26-076085","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2026-06-22T11:38:15+00:00","items":["8.01"],"status":"ready","headline":"Select Medical supplements merger proxy with deal fees, DCF details after stockholder suits","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Three lawsuits in NY and PA allege proxy omissions; company denies but voluntarily adds disclosures.","Adds $2.9M fee to Ortenzio and $0.2M to Jackson for roles in structuring the transaction.","Board explored separating critical illness recovery hospital segment from late June 2025.","Goldman Sachs DCF valuation range per share: $15.04-$25.33; net debt $1.818B; 17 precedent deal premia added.","Special meeting on merger remains scheduled for June 26, 2026; company urges stockholders to vote."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":92074,"accession_number":"0001104659-26-053056","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2026-04-30T23:59:59+00:00","items":["2.02","5.02","8.01","9.01"],"status":"ready","headline":"Select Medical Q1 EPS $0.35 vs $0.44; revenue +5% to $1.42B; merger on track","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $1,421.5M +5.0% YoY; net income $63.8M vs $74.7M; diluted EPS $0.35 vs $0.44.","Adj EBITDA $141.6M down from $151.4M; critical illness hospital margin fell to 11.5% from 13.6%.","Rehab hospital revenue +14.5% to $351.9M, Adj EBITDA +15.1% to $81.1M, margin stable at 23.0%.","Merger with WCAS XIV on track; HSR waiting period expired Apr 27; expected close mid-2026 at $16.50/share.","FY 2026 outlook reaffirmed: rev $5.6-5.8B, Adj EBITDA $520-540M, diluted EPS $1.22-1.32."],"consensus_eps_estimate":null,"consensus_eps_actual":0.35,"consensus_revenue_estimate":null,"consensus_revenue_actual":1421476000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":92073,"accession_number":"0001104659-26-048634","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2026-04-24T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Select Medical shareholders approve board declassification, special meeting at 25% threshold","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Three Class II directors elected with >98% support; say-on-pay approved with 97% of votes cast.","Amendment to phase out classified board approved (113.8M for, 233,759 against); board will become annually elected.","Company special meeting at 25% threshold passed (96.4M for); shareholder proposal at 10% threshold rejected (91.2M against).","Ratification of PwC as auditor for FY2026 approved (116.3M for, 1.5M against)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.15,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":102615,"accession_number":"0001104659-26-022577","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2026-03-03T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Select Medical to be acquired by consortium led by Ortenzio, Jackson, WCAS for $16.50/share","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Enterprise value of $3.9B; Merger Consideration of $16.50 per share in cash.","Premium of ~18% over unaffected price (Nov 24, 2025) and ~25% over 90-day VWAP.","Ortenzio, Jackson and certain affiliates rolling over ~11.8% equity stakes; will vote in favor.","Closing expected mid-2026, subject to stockholder approval, HSR, and regulatory clearances.","Company termination fee $66.5M; Parent termination fee $133.0M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":102614,"accession_number":"0001104659-26-017585","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2026-02-19T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Select Medical reports Q4 growth, 2026 outlook; Ortenzio take-private bid under review","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $1,396.6M (+6.4%), net income $37.7M, diluted EPS $0.16 vs loss $0.19 YoY.","FY2025 revenue $5,452.8M (+5.1%), net income $214.5M (+65%), adjusted EPS $1.16 (+23.4%).","Rehab hospital segment revenue +15.2%, Adj EBITDA +11.1%. Outpatient rehab margin fell to 3.4% from 8.3%.","2026 outlook: revenue $5.6-5.8B, Adj EBITDA $520-540M, diluted EPS $1.22-1.32.","Board declares $0.0625 dividend; $1B stock repurchase authorized through Dec 2027; Ortenzio take-private proposal under review."],"consensus_eps_estimate":null,"consensus_eps_actual":1.16,"consensus_revenue_estimate":null,"consensus_revenue_actual":5452830000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118858,"accession_number":"0001104659-25-123153","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2025-12-19T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Select Medical enters new CEO employment agreement with Thomas Mullin effective Jan 1, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["1-year initial term, auto-renewing; base salary $700,000/year.","Termination without cause: 12 months base salary continuation.","Non-compete and non-solicitation covenants apply for 2 years post-termination.","Change of control terms governed by prior February 2021 letter."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118857,"accession_number":"0001104659-25-115701","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2025-11-25T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Select Medical receives take-private proposal from Executive Chairman at $16-$16.20/share","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Non-binding proposal to acquire all outstanding shares for $16.00-$16.20 cash per share.","Proposal submitted by Robert A. Ortenzio, Executive Chairman, Co-Founder, and Director, via Schedule 13D.","Disinterested board members are reviewing the proposal with advisors.","No assurance of outcome; company will not comment further unless required."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118856,"accession_number":"0001104659-25-104425","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2025-10-30T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Select Medical Q3 revenue up 7.2% to $1.36B, EPS $0.23; raises FY25 EPS guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenue $1,363.4M (+7.2% YoY); income from cont ops $44.2M (+7%); Adj EBITDA $111.7M (+7.5%).","EPS from cont ops $0.23 vs $0.19 (+21.1%); adjusted EPS $0.23 vs $0.26 (-11.5%).","Rehab hospital rev +16.2% to $328.6M; outpatient rehab EBITDA margin fell to 7.4% from 9.1%.","FY25 outlook: revenue $5.3-5.5B, Adj EBITDA $510-530M, diluted EPS $1.14-1.24 (raised).","Dividend $0.0625/share declared; stock buyback program extended to Dec 31, 2027."],"consensus_eps_estimate":null,"consensus_eps_actual":1.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":4056196000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":135393,"accession_number":"0001104659-25-086392","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2025-09-02T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Select Medical names Thomas P. Mullin CEO; David Chernow becomes Vice Chairman","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Mullin, 41, promoted from Co-President, effective Sept 1, 2025; Chernow (CEO since 2014) becomes Vice Chairman.","John A. Saich becomes sole President (was Co-President); retains oversight of outpatient rehab and shared services.","John F. Duggan appointed EVP, General Counsel and Secretary; Michael Tarvin transitions to senior EVP of legal services.","Mullin joined Select Medical in 2008, most recently oversaw 140 critical illness recovery and inpatient rehab hospitals.","All changes effective immediately; company cites internal succession planning with long-tenured leaders."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":135392,"accession_number":"0001104659-25-073383","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2025-08-04T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Select Medical amends bylaws to tighten stockholder nomination rules under universal proxy","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Board adopted Amended and Restated Bylaws on July 30, 2025.","Stockholders must now represent intent to solicit proxies from at least 67% voting power for director elections.","Stockholders must provide evidence of proxy solicitation to the company.","Amendments also clarify and enhance other advanced notice procedural requirements.","Changes align with SEC Rule 14a-19 under the universal proxy framework."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":135391,"accession_number":"0001104659-25-072731","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2025-07-31T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Select Medical Q2 revenue +4.5% to $1.34B, EPS $0.32, reaffirms FY2025 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $1,339.6M (+4.5% YoY); net income from continuing ops $57.9M (+53.8%).","Adjusted EBITDA $125.4M (+0.5% YoY); diluted EPS $0.32 vs $0.17 (+88.2%).","Rehab hospital revenue +17.2% to $313.8M; critical illness revenue -0.6% to $601.1M.","Reaffirms FY2025 revenue $5.3B-$5.5B, Adj EBITDA $510M-$530M, EPS $1.09-$1.19.","Declares $0.0625/share cash dividend (payable Aug 28); $1B buyback program ongoing."],"consensus_eps_estimate":null,"consensus_eps_actual":0.76,"consensus_revenue_estimate":null,"consensus_revenue_actual":2692751000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":152378,"accession_number":"0001104659-25-043544","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2025-05-01T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Select Medical Q1 revenue up 2.4%, EPS rises 33% but core segment weakens; guidance lowered","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $1,353.2M (+2.4% YoY); net income from cont. ops $74.7M (+21.5%); EPS $0.44 (+33.3%).","Critical illness recovery hospital revenue declined 2.9% to $637.0M, segment Adjusted EBITDA down 25.3% to $86.6M.","Rehabilitation hospital revenue up 15.7% to $307.4M, segment Adjusted EBITDA up 14.7% to $70.4M.","Declared quarterly dividend $0.0625/share, payable May 29 to holders of record May 15.","FY2025 guidance lowered: revenue $5.3B-$5.5B (prev. $5.4B-$5.6B), Adj. EBITDA $510M-$530M (prev. $530M-$550M)."],"consensus_eps_estimate":null,"consensus_eps_actual":0.44,"consensus_revenue_estimate":null,"consensus_revenue_actual":1353172000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":152377,"accession_number":"0001104659-25-041376","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2025-04-29T23:59:59+00:00","items":["5.02","5.03","5.07","9.01"],"status":"ready","headline":"Select Medical shareholders approve director comp policy and eliminate supermajority voting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders approved a Non-Employee Director Compensation Policy with $18,000 quarterly cash retainer and $200,000 annual equity grant.","Charter amended to eliminate supermajority voting requirements; voting threshold reduced to majority of outstanding shares.","Bylaws amended to reduce voting threshold to majority for amending bylaws and removing directors for cause.","Four Class I directors elected: Russell Carson, Katherine Davisson, William Frist, Marilyn Tavenner."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":171214,"accession_number":"0001104659-25-015705","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2025-02-20T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Select Medical Q4 revenue +7.8% to $1.31B, adjusted EPS +50%; issues 2025 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $1.31B (+7.8% YoY); loss from continuing ops $10.5M vs profit $30.3M (impacted by $45.9M stock comp acceleration and $17.9M debt retirement loss).","Adjusted EPS from continuing ops $0.18 (+50% YoY); full-year adjusted EPS $0.94 (+74.1%).","Rehabilitation hospital segment Q4 margin declined to 21.2% from 25.5%; outpatient rehab full-year margin down to 8.7% from 9.4%.","Completed tax-free distribution of Concentra; no longer owns any shares.","2025 outlook: revenue $5.4-5.6B, Adj EBITDA $520-540M, diluted EPS $1.09-1.19."],"consensus_eps_estimate":null,"consensus_eps_actual":1.66,"consensus_revenue_estimate":null,"consensus_revenue_actual":5187105000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":188185,"accession_number":"0001104659-24-125495","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-12-04T23:59:59+00:00","items":["1.01","2.03","8.01","9.01"],"status":"ready","headline":"Select Medical closes $550M 6.250% senior notes due 2032; amends credit agreement with $1.05B term loan","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Net proceeds used to repay existing term loans and redeem all outstanding 6.250% Senior Notes due 2026.","Amendment No. 11 adds $1.05B incremental term loan and extends revolver to 5 years; $50M incremental revolver commitment added.","Interest on new notes is 6.250% payable semi-annually; matures December 2032."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":188184,"accession_number":"0001104659-24-123173","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-11-26T23:59:59+00:00","items":["2.01","9.01"],"status":"ready","headline":"Select Medical completes spin-off of Concentra, distributing 104M shares worth $2.3B","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["104,093,503 shares of Concentra (81.7% stake) distributed to Select stockholders as of Nov 18 record date.","Stockholders received 0.806971 Concentra shares per Select share; cash in lieu of fractional shares.","Aggregate market value of distributed shares ~$2.3B based on $22.13 closing price on Nov 25, 2024.","Pro forma financials reflect separation; planned $550M 6.250% notes due 2032 and $1.05B term loan to repay debt.","After distribution, Select Medical holds no shares of Concentra common stock."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":188183,"accession_number":"0001104659-24-120415","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-11-19T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Select Medical Corp prices $550M of 6.250% Senior Notes due 2032 to refinance existing debt","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$550M aggregate principal of 6.250% Senior Notes due 2032 priced; closing expected Dec 3, 2024.","Notes are senior unsecured obligations guaranteed by certain domestic subsidiaries.","Proceeds will repay existing term loans and redeem all outstanding 6.250% Senior Notes due 2026.","Concurrently, Select intends to amend its credit agreement to add incremental term loan and extend revolving credit maturity.","Offering is private under Rule 144A/Reg S; notes not registered."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":188182,"accession_number":"0001104659-24-120386","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-11-19T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Select Medical sets final distribution ratio of 0.806971 Concentra shares per SEM share; distribution Nov 25","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Final ratio: 0.806971 shares of Concentra (CON) per SEM share; based on 128,992,850 SEM shares outstanding as of Record Date Nov 18.","Distribution of 104,093,503 CON shares (81.7% of CON) on Nov 25; no fractional shares, cash in lieu.","After distribution, Select Medical will own no CON shares; distribution intended tax-free for U.S. holders.","Shares trade with due bills in regular-way market through Distribution Date; ex-distribution market also available."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":188181,"accession_number":"0001104659-24-119970","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-11-18T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Select Medical Corp. announces $850M senior notes offering and $750M term loan to refinance existing debt","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Select Medical Corporation plans $850M senior notes due 2032 in a private placement; notes guaranteed by certain domestic subsidiaries.","Concurrently, it will amend credit facilities to add a $750M incremental term loan, extend revolver to 5 years, and add $50M revolver.","Proceeds from notes, new term loan, and cash on hand will repay existing term loan and redeem all outstanding 6.250% senior notes due 2026.","The offering is subject to market conditions and other customary conditions; no assurance it will be completed as described."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":188180,"accession_number":"0001104659-24-114906","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-11-07T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Select Medical spins off 81.7% Concentra stake via special stock distribution","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Distribution of 104,093,503 Concentra shares (81.7% of CON) to SEM stockholders on Nov 25, 2024.","Record date Nov 18, 2024; stockholders receive ~0.806971 CON shares per SEM share.","No stockholder vote required; distribution intended to be tax-free for U.S. federal income tax purposes.","After distribution, Select Medical will own no shares of Concentra common stock.","J.P. Morgan and Goldman Sachs acting as financial advisors; Dechert LLP as legal advisor."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":188179,"accession_number":"0001104659-24-113096","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-10-31T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Select Medical Q3 revenue up 5.7% to $1.76B; net income +33.2%; dividend $0.125; FY guidance updated","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenue $1,761.2M (+5.7% YoY); net income $81.0M (+33.2%); adjusted EPS $0.50 (+8.7%).","Segment Adj. EBITDA: Critical Illness +9.5%, Rehab Hospital +12.1%, Concentra +2.7%.","FY2024 guidance: revenue $6.95B–$7.15B; Adj. EBITDA $865M–$885M; adj. EPS $2.09–$2.20.","Dividend $0.125/share declared, payable Nov 26 to holders of record Nov 13, 2024.","No share repurchases in Q3; $600.3M total buybacks since program inception."],"consensus_eps_estimate":null,"consensus_eps_actual":1.78,"consensus_revenue_estimate":null,"consensus_revenue_actual":5309692000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":204681,"accession_number":"0001104659-24-084960","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-08-01T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Ortenzio resigns; CEO Chernow appointed to board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Rocco Ortenzio resigned as director effective August 1, 2024, with no disagreement with the company.","CEO David Chernow appointed as director effective August 1, 2024 to fill the vacancy; remains CEO.","Chernow's director term expires at the 2027 annual meeting; no special arrangement with any person."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":204680,"accession_number":"0001104659-24-084955","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-08-01T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Select Medical Q2 revenue up 5.1% to $1.76B, EPS $0.60; Concentra IPO raises $528.8M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 rev $1,759.7M (+5.1% YoY), net income $94.8M (+3.2%), GAAP EPS $0.60 vs $0.61 prior.","Adj EBITDA $226.3M (+3.1%); FY2024 guidance reaffirmed (rev $6.9-7.1B, adj EPS $1.96-2.20).","Concentra IPO raised $528.8M (22.5M shares at $23.50); also issued $650M 6.875% Senior Notes due 2032.","IPO & debt proceeds repaid $1.9B of Select credit facilities; $0.125/shr dividend declared."],"consensus_eps_estimate":null,"consensus_eps_actual":1.35,"consensus_revenue_estimate":null,"consensus_revenue_actual":3548472000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":204679,"accession_number":"0001104659-24-084488","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-08-01T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Select Medical completes Concentra IPO of 22.5M shares at $23.50, retains ~82% stake","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["IPO of 22.5M shares of Concentra common stock at $23.50/share; net proceeds $499.7M.","IPO proceeds paid to SMC to repay intercompany debt; SMC retains ~82.23% of Concentra.","Select credit agreement amended; revolving commitments reduced from $770M to $550M.","Concentra entered into $1.25B credit facilities ($850M term loan, $400M revolver).","Concentra assumed $650M of 6.875% senior notes due 2032."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":204678,"accession_number":"0001104659-24-080552","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-07-17T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Select Medical subsidiary issues $650M 6.875% Senior Notes due 2032","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$650M aggregate principal of 6.875% senior notes due July 15, 2032, issued by Concentra Escrow Issuer Corp.","$50M of net proceeds for general corporate purposes; remainder paid to Select Medical Corp as a dividend.","Notes are part of financing for planned separation of Concentra; merger with Concentra Health Services pending.","If merger not consummated by Sep 30, 2024, notes subject to special mandatory redemption at 100% plus accrued interest.","Interest payable semi-annually on Jan 15 and Jul 15, starting Jan 15, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":204677,"accession_number":"0001104659-24-079579","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-07-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Select Medical estimates Concentra Q2 rev $477.9M, op income $83.9M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Concentra net operating revenue ~$477.9M for Q2 2024; income from operations ~$83.9M.","Estimates are preliminary, subject to change upon completion of financial close.","Select Medical's full Q2 2024 results expected after market close on August 1, 2024.","Conference call to discuss results and outlook on August 2, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":1.35,"consensus_revenue_estimate":null,"consensus_revenue_actual":3548472000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":221519,"accession_number":"0001104659-24-075765","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-06-27T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Select Medical's Concentra subsidiary prices $650M of 6.875% senior notes due 2032","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$650M aggregate principal of 6.875% senior notes due 2032 priced by Concentra Escrow Issuer.","Notes issued as a step in the planned separation of Concentra from Select Medical.","Proceeds held in escrow pending merger into CHSI expected Q3 2024; if not closed by Sep 30, notes subject to special mandatory redemption at 100% plus accrued interest.","Concentra to use $50M for corporate purposes; remainder plus borrowings paid as dividend to Select Medical Corp.","Upon merger, notes guaranteed by Concentra and certain subsidiaries on senior unsecured basis."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":221518,"accession_number":"0001104659-24-056432","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-05-02T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Select Medical reports Q1 2024 revenue $1.79B (+7.4%), adj EPS $0.77 (+37.5%); declares $0.125 dividend; updates outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $1,788.8M (+7.4% YoY); net income $117.2M (+37.4%); GAAP EPS $0.75 (+33.9%).","Adjusted EPS $0.77 (+37.5% YoY); Adjusted EBITDA $261.9M (+22.4% YoY).","Critical illness recovery hospital segment adjusted EBITDA $115.9M (+51.0%); margin improved to 17.7%.","Reaffirms 2024 revenue outlook $6.9-7.1B; adjusts EBITDA outlook to $845-885M; adj EPS outlook $1.96-2.20.","Declares cash dividend $0.125 per share, payable May 30, 2024 to holders of record May 16."],"consensus_eps_estimate":null,"consensus_eps_actual":0.75,"consensus_revenue_estimate":null,"consensus_revenue_actual":1788809000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":221517,"accession_number":"0001104659-24-052995","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-04-26T23:59:59+00:00","items":["5.02","5.03","5.07","9.01"],"status":"ready","headline":"Shareholders approve expanded equity plan and officer exculpation at annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders approved amendment to 2020 Equity Incentive Plan, increasing share reserve to 5,925,000 shares and adding minimum one-year vesting.","Shareholders approved charter amendment to exculpate officers from certain fiduciary duty breaches, effective April 26, 2024.","Three Class III directors (Ely, Ortenzio, Scully) re-elected; non-binding advisory votes on executive compensation and simple majority proposal passed.","Ratification of PricewaterhouseCoopers as independent auditor for fiscal year 2024 approved with 122,477,547 votes for.","All seven proposals at the April 25, 2024 Annual Meeting were approved."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":241054,"accession_number":"0001104659-24-026568","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-02-22T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Select Medical Q4 net income +63.9%, FY EPS $1.91; issues 2024 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $1,658.9M (+4.9% YoY); net income $61.8M (+63.9%); EPS $0.36 (+63.6%).","FY 2023 revenue $6,664.1M (+5.2%); net income $299.7M (+51.4%); adjusted EPS $1.99 (+61.8%).","Critical illness recovery hospital segment FY Adjusted EBITDA surged 121% to $246.0M.","Board declared $0.125/share dividend payable March 13, 2024; $1B stock buyback authorized through 2025.","2024 outlook: revenue $6.9B–$7.1B, Adjusted EBITDA $830M–$880M, EPS $1.88–$2.18."],"consensus_eps_estimate":null,"consensus_eps_actual":1.91,"consensus_revenue_estimate":null,"consensus_revenue_actual":6664058000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":258540,"accession_number":"0001104659-23-113833","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2023-11-02T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Select Medical Q3 revenue $1.67B (+6.2%), EPS $0.38 (+75.8%), maintains FY outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenue $1,665.7M (+6.2% YoY); net income $60.8M (+59.5%).","Q3 adjusted EBITDA $193.8M (+26.6%); adjusted EPS $0.46 (+113.7%).","Critical illness recovery hospital segment Adjusted EBITDA surged 321% to $46.4M.","FY 2023 outlook maintained: revenue $6.55B-$6.7B, Adj. EBITDA $795M-$825M, EPS $1.77-$1.94.","Board declared $0.125/share dividend payable Nov 28; $1.0B stock repurchase program authorized."],"consensus_eps_estimate":null,"consensus_eps_actual":1.55,"consensus_revenue_estimate":null,"consensus_revenue_actual":5005202000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":275841,"accession_number":"0001104659-23-098970","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2023-09-07T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Select Medical names Saich, Mullin Co-Presidents; Malatesta CFO effective Oct 1","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["John Saich and Thomas Mullin become Co-Presidents; David Chernow remains CEO. Effective Oct 1, 2023.","Michael Malatesta appointed CFO; Martin Jackson elevates to SEVP Strategic Finance & Operations.","Saich (26-year veteran) oversaw Outpatient Rehab; Mullin led Critical Illness Recovery Hospital Operations.","Other promotions: Tarvin to SEVP General Counsel, Hollenbach to EVP Strategy & Growth, among 12 total."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":275840,"accession_number":"0001104659-23-097786","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2023-09-01T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Select Medical increases revolving credit facility by $60M to $770M via Amendment No. 9","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Revolving credit commitments raised from $710M to $770M, effective August 31, 2023.","Capital One, National Association provides $60M incremental revolving commitment as a new lender.","Amendment includes customary post-closing covenants regarding mortgages and flood matters.","No events of default or material adverse change; representations reaffirmed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":275839,"accession_number":"0001104659-23-087347","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2023-08-03T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Select Medical Q2 EPS $0.61 (+44% YoY), revenue up 5.7%; declares $0.125 dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 revenue $1,674.5M (+5.7% YoY); net income $91.9M (+38.6% YoY); Adjusted EBITDA $219.5M (+21.3% YoY).","Critical illness recovery hospital segment Adjusted EBITDA surged 227% to $65.5M; margin 11.4% vs 3.7%.","Board declared $0.125/share cash dividend, payable Sep 1, 2023 to holders of record Aug 15.","FY2023 outlook: revenue $6.55-6.7B, Adjusted EBITDA $795-825M, EPS $1.77-1.94, adjusted EPS $1.86-2.03.","No shares repurchased in H1 2023; $1.0B buyback program expires Dec 31, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":1.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":3339508000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":275838,"accession_number":"0001104659-23-086804","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2023-08-02T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Bryan Cressey resigns; Select Medical awards 1.05M restricted shares to executives","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Director Bryan C. Cressey resigned effective Aug 2, 2023; no disagreement with company or board.","Compensation Committee granted 1,050,000 restricted shares to seven executives under 2020 Equity Plan.","David Chernow and Robert Ortenzio each received 250,000 shares; Rocco Ortenzio and Martin Jackson each 150,000.","Shares for Chernow, R. Ortenzio, Jackson, Tarvin vest equally over 3 years; Saich and Mullin vest on Aug 1, 2026.","Michael Tarvin received 100,000 shares; Saich and Mullin each 75,000 shares."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":275837,"accession_number":"0001104659-23-086339","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2023-08-01T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Select Medical refinances $2.8B credit facilities, extends maturity to 2027","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $2,103.0M tranche of refinancing term loans replaces existing term loans.","New $710.0M revolving credit facility replaces existing revolver.","Maturity extended to March 6, 2027; springing maturity if >$300M senior notes outstanding.","$60M incremental revolving commitment from Mizuho Bank added on July 31, 2023.","Upfront fees: 0.15% on extended revolver, 0.50% on term loan conversion, 0.30% on incremental revolver."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":275836,"accession_number":"0001104659-23-082364","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2023-07-19T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Select Medical Q2 estimates: revenue ~$1.67B, Adj EBITDA ~$219M, EPS ~$0.61; in refinancing talks","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net operating revenue expected ~$1.67B for Q2 ended June 30, 2023.","Adjusted EBITDA ~$219M; fully diluted EPS ~$0.61.","As of June 30, 2023, cash ~$100M; indebtedness ~$3.75B.","Company in discussions with lenders regarding proposed refinancing of certain debt.","Actual Q2 results to be announced after market close on August 3, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":1.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":3339508000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":293445,"accession_number":"0001104659-23-068527","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2023-06-06T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Select Medical amends credit agreement, extends $60M revolver maturity to 2025, transitions to SOFR","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Replaces LIBOR with Adjusted Term SOFR for borrowings under the credit agreement.","Extends maturity on $60M of revolving capacity to March 6, 2025; $590M total extended, $60M remains March 6, 2024.","Royal Bank of Canada converts its non-extended revolver to extended, with pro rata adjustments.","Amendment effective May 31, 2023; conditions satisfied including fees and documentation.","No default or material adverse change representations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":293444,"accession_number":"0001104659-23-056064","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2023-05-04T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Select Medical Q1 revenue up 4.1% to $1.665B; net income up 52.4%; declares $0.125 dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $1,665M (+4.1% YoY); net income $85.3M (+52.4%); EPS $0.56 (+51.3%).","Adjusted EBITDA $214.1M (+30.6%); operating income $151.5M (+45.7%).","Critical illness recovery hospital segment Adjusted EBITDA surged 113.5% to $76.8M; other segments also grew.","Declared $0.125/share dividend payable May 31 to holders of record May 18.","FY 2023 outlook: revenue $6.5B-$6.7B; Adjusted EBITDA $780M-$820M; EPS $1.75-$1.99."],"consensus_eps_estimate":null,"consensus_eps_actual":0.56,"consensus_revenue_estimate":null,"consensus_revenue_actual":1664980000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":293443,"accession_number":"0001104659-23-051310","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2023-04-27T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Select Medical Holdings announces 2023 annual meeting voting results","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Four Class II directors elected: Bryan Cressey, Parvinderjit Khanuja, Robert Ortenzio, Daniel Thomas.","Non-binding advisory vote on executive compensation passed with ~87% of votes cast in favor.","Advisory vote on frequency of compensation votes set at 1 year (116,335,529 votes).","Ratification of PricewaterhouseCoopers as independent auditor for 2023 approved with ~99.2% of votes cast in favor."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":314081,"accession_number":"0001104659-23-027310","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2023-03-01T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Select Medical appoints Christopher Weigl as CAO; Romberger resigns","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Scott Romberger resigned as CAO effective March 1, 2023; remains as Executive Advisor, Financial Shared Services.","Christopher Weigl appointed SVP, Controller & CAO effective March 1, 2023.","Weigl previously SVP Corporate Accounting Services since Aug 2022; base salary $450k, eligible for 60% bonus.","Weigl received sign-on bonus $80k, 12,500 restricted shares (4-year cliff vesting) per April 2022 offer letter."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":314080,"accession_number":"0001104659-23-024791","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2023-02-23T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Select Medical Q4 revenue $1.58B (+1.4%), EPS $0.22; FY22 revenue $6.33B, EPS $1.23; declares $0.125 dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $1,581.5M (+1.4% YoY); net income $37.7M (down 43%); EPS $0.22 vs $0.37.","FY22 revenue $6,333.5M (+2.1%); net income $198.0M (down 60%); EPS $1.23 vs $2.98.","Critical illness recovery hospital Q4 Adj EBITDA +80.5% to $44.3M; rehab hospital +42.5% to $56.0M.","Board declared $0.125/share cash dividend payable March 15, 2023 to holders of record March 3, 2023.","2023 revenue guidance $6.5B-$6.7B; no Adj EBITDA/EPS guidance due to labor uncertainties."],"consensus_eps_estimate":null,"consensus_eps_actual":1.23,"consensus_revenue_estimate":null,"consensus_revenue_actual":6333538000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":314079,"accession_number":"0001104659-23-024295","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2023-02-22T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Select Medical extends $530M revolver maturity to 2025 via Amendment No. 6","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Extends maturity on $530M of $650M revolving facility to March 6, 2025 (or Jan 3, 2025 if term loan not refinanced).","Remaining $120M of revolver commitments continue to mature on March 6, 2024.","Amendment No. 6 entered Feb 21, 2023 with JPMorgan Chase as administrative agent.","Upfront fee of 0.10% of aggregate revolving commitments paid to each revolving lender.","Borrower represented no Event of Default or Default continuing as of effective date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":332519,"accession_number":"0001104659-22-114448","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2022-11-03T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Select Medical Q3 net income drops 62% to $38.1M; EPS $0.21 vs $0.57","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $1,567.8M (+2.2% YoY); net income $38.1M vs $100.2M; EPS $0.21 vs $0.57.","Adjusted EBITDA fell to $153.1M from $208.6M; operating income $91.5M vs $150.3M.","Critical illness recovery hospital segment Adjusted EBITDA plunged to $11.0M from $57.2M; margin 2.1% vs 10.8%.","Board declared $0.125 per share dividend, payable Nov 29 to holders of record Nov 16.","Reaffirmed FY2022 revenue outlook of $6.25-6.40B; labor climate delays EBITDA and EPS guidance."],"consensus_eps_estimate":null,"consensus_eps_actual":1.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":4752082000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":349989,"accession_number":"0001104659-22-086224","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2022-08-04T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Select Medical Q2 net income falls 66% to $66.3M; EPS $0.43 vs $1.22","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $1,584.7M (+1.3% YoY); net income $66.3M vs $196.2M; diluted EPS $0.43 vs $1.22.","Adjusted EBITDA $181.0M vs $342.0M; includes $15.1M Provider Relief Fund income (prior year $98.0M).","Critical illness recovery hospital segment Adjusted EBITDA plunged to $20.0M from $72.9M; margin 3.7% vs 13.4%.","Board declared $0.125/share cash dividend payable Sept 2, 2022 to holders of record Aug 16, 2022.","Reaffirms FY2022 revenue outlook $6.25B-$6.40B; defers Adjusted EBITDA/EPS guidance until labor market stabilizes."],"consensus_eps_estimate":null,"consensus_eps_actual":0.79,"consensus_revenue_estimate":null,"consensus_revenue_actual":3184288000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":349988,"accession_number":"0001104659-22-086061","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2022-08-04T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Select Medical awards 900,000 restricted shares to top executives under 2020 Plan","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Total of 900,000 restricted shares awarded to five named executive officers.","Shares vest equally over three years from grant date August 1, 2022.","CEO David Chernow and Vice Chairman Robert Ortenzio each received 250,000 shares.","President Rocco Ortenzio and CFO Martin Jackson each received 150,000 shares.","EVP, General Counsel Michael Tarvin received 100,000 shares."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":367101,"accession_number":"0001104659-22-056505","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2022-05-05T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Select Medical Q1 net income drops 59% to $55.9M; revenue up 3.4% to $1.60B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Adjusted EBITDA fell 37% to $163.8M from $258.3M; operating income $104.0M vs $202.0M.","EPS $0.37 vs $0.82; critical illness hospital segment Adjusted EBITDA margin fell to 6.0% from 19.0%.","Dividend of $0.125 per share declared; payable June 1, 2022 to holders of record May 19, 2022.","Reaffirmed FY2022 revenue outlook $6.25B-$6.40B; labor climate cited for withholding EBITDA and EPS outlook.","Concentra segment Adjusted EBITDA up 9.1% to $89.5M with 21.1% margin; repurchased 2.1M shares in Q1."],"consensus_eps_estimate":null,"consensus_eps_actual":0.37,"consensus_revenue_estimate":null,"consensus_revenue_actual":1599547000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":367100,"accession_number":"0001104659-22-053509","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2022-04-29T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Select Medical shareholders elect directors, approve exec comp, ratify auditor at 2022 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Four Class I directors elected: Carson, Davisson, Frist, Tavenner received 113M–124M votes for each.","Advisory vote on executive compensation passed: 108.4M for, 16.6M against, 2.8M broker non-votes.","Ratification of PwC as auditor approved: 126.8M for, 1.0M against, no broker non-votes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.0,"calibrated_materiality_score":0.0,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-04-29T23:59:59+00:00|367100"}